Ferrante Karen Jean is a director of Macrogenics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Cogent Biosciences, Inc.
2 Apr 24
4
Cogent Biosciences, Inc.
4 Jan 24
4
Cogent Biosciences, Inc.
3 Oct 23
4
Cogent Biosciences, Inc.
5 Jul 23
4
Cogent Biosciences, Inc.
8 Jun 23
4
MACROGENICS INC
2 Jun 23
4
Cogent Biosciences, Inc.
4 Apr 23
4
Cogent Biosciences, Inc.
4 Jan 23
4
Cogent Biosciences, Inc.
4 Oct 22
4
Cogent Biosciences, Inc.
5 Jul 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Apr 24 | COGT Cogent Biosciences | Stock Option Common Stock | Grant | Acquire A | No | No | 6.9 | 3,213 | 22.17 k | 3,213 |
2 Jan 24 | COGT Cogent Biosciences | Stock Option Common Stock | Grant | Acquire A | No | No | 6.24 | 3,298 | 20.58 k | 3,298 |
2 Oct 23 | COGT Cogent Biosciences | Stock Option Common Stock | Grant | Acquire A | No | No | 9.55 | 2,345 | 22.39 k | 2,345 |
7 Jun 23 | COGT Cogent Biosciences | Stock Option Common Stock | Grant | Acquire A | No | No | 11.7 | 36,700 | 429.39 k | 36,700 |
31 May 23 | MGNX Macrogenics | RSU Common Stock | Grant | Acquire A | No | No | 0 | 4,500 | 0.00 | 4,500 |
31 May 23 | MGNX Macrogenics | Stock Option Common Stock | Grant | Acquire A | No | No | 4.67 | 19,000 | 88.73 k | 19,000 |